These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 37251668
1. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants. Mancioppi V, Pozzi E, Zanetta S, Missineo A, Savastio S, Barbetti F, Mellone S, Giordano M, Rabbone I. Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668 [Abstract] [Full Text] [Related]
2. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of KATP-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital. Ngoc CTB, Dien TM, De Franco E, Ellard S, Houghton JAL, Lan NN, Thao BP, Khanh NN, Flanagan SE, Craig ME, Dung VC. Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892 [Abstract] [Full Text] [Related]
4. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, Flanagan SE, Babiker T, Thomas NJ, Shepherd MH, Ellard S, Klimes I, Szopa M, Polak M, Iafusco D, Hattersley AT, Njølstad PR, Neonatal Diabetes International Collaborative Group. Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308 [Abstract] [Full Text] [Related]
5. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus. Kylat RI, Senguttuvan R, Bader MY. J Pediatr Endocrinol Metab; 2017 May 01; 30(5):593-596. PubMed ID: 28350539 [Abstract] [Full Text] [Related]
6. Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant. Siklar Z, Ellard S, Okulu E, Berberoğlu M, Young E, Savaş Erdeve S, Mungan IA, Hacihamdioğlu B, Erdeve O, Arsan S, Oçal G. J Pediatr Endocrinol Metab; 2011 May 01; 24(11-12):1077-80. PubMed ID: 22308870 [Abstract] [Full Text] [Related]
9. Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea. Lau E, Correia C, Freitas P, Nogueira C, Costa M, Saavedra A, Costa C, Carvalho D, Fontoura M. Arch Endocrinol Metab; 2015 Dec 01; 59(6):559-61. PubMed ID: 26331221 [Abstract] [Full Text] [Related]
10. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea. Taberner P, Flanagan SE, Mackay DJ, Ellard S, Taverna MJ, Ferraro M. Diabetes Res Clin Pract; 2016 Jul 01; 117():104-10. PubMed ID: 27329029 [Abstract] [Full Text] [Related]
15. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child. Yang W, Wei H, Sang Y. J Pediatr Endocrinol Metab; 2013 Mar 09; 26(5-6):591-4. PubMed ID: 23640936 [Abstract] [Full Text] [Related]